Radiation dosimetry of [18F]VAT in nonhuman primates

[1] Di Paolo T(2014)AQW051, a novel and selective nicotinic acetylcholine receptor alpha7 partial agonist, reduces l-Dopa-induced dyskinesias and extends the duration of l-Dopa effects in parkinsonian monkeys Parkinsonism Relat Disord 20 1119-23

[2] Gregoire L(2014)ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson’s disease Mov Disord 29 508-17

[3] Feuerbach D(2013)Thalamic cholinergic innervation and postural sensory integration function in Parkinson’s disease Brain 136 3282-9

[4] Elbast W(2014)Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson’s disease Front Aging Neurosci 6 213-71

[5] Weiss M(2014)Nicotinic alpha4beta2 acetylcholine receptors and cognitive function in Parkinson’s disease Acta Neurol Scand 130 164-49

[6] Gomez-Mancilla B(2009)Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine Brain 132 2336-9

[7] Zhang D(1976)Selective loss of central cholinergic neurons in Alzheimer’s disease Lancet 2 1403-80

[8] Bordia T(1982)Alzheimer’s disease and senile dementia: loss of neurons in the basal forebrain Science 215 1237-9

[9] McGregor M(2014)In vitro and in vivo characterization of two C-11-labeled PET tracers for vesicular acetylcholine transporter Mol Imaging Biol 16 773-69

[10] McIntosh JM(2010)Synthesis and evaluation of 15-(4-(2-[ Bioconjug Chem 21 2313-204

[1] Di Paolo T(2014)AQW051, a novel and selective nicotinic acetylcholine receptor alpha7 partial agonist, reduces l-Dopa-induced dyskinesias and extends the duration of l-Dopa effects in parkinsonian monkeys Parkinsonism Relat Disord 20 1119-23

[2] Gregoire L(2014)ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson’s disease Mov Disord 29 508-17

[3] Feuerbach D(2013)Thalamic cholinergic innervation and postural sensory integration function in Parkinson’s disease Brain 136 3282-9

[4] Elbast W(2014)Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson’s disease Front Aging Neurosci 6 213-71

[5] Weiss M(2014)Nicotinic alpha4beta2 acetylcholine receptors and cognitive function in Parkinson’s disease Acta Neurol Scand 130 164-49

[6] Gomez-Mancilla B(2009)Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine Brain 132 2336-9

[7] Zhang D(1976)Selective loss of central cholinergic neurons in Alzheimer’s disease Lancet 2 1403-80

[8] Bordia T(1982)Alzheimer’s disease and senile dementia: loss of neurons in the basal forebrain Science 215 1237-9

[9] McGregor M(2014)In vitro and in vivo characterization of two C-11-labeled PET tracers for vesicular acetylcholine transporter Mol Imaging Biol 16 773-69

[10] McIntosh JM(2010)Synthesis and evaluation of 15-(4-(2-[ Bioconjug Chem 21 2313-204